Penserra Capital Management LLC 23and Me Holding Co. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.19 - $3.98 $10,181 - $18,503	4,649 Added 86.56%	10,020 $24,000
Q1 2022 May 13, 2022	BUY	$3.28 - $7.12 $4,818 - $10,459	1,469 Added 37.65%	5,371 $20,000
Q4 2021 Feb 15, 2022	SELL	$6.55 - $13.25 $34,590 - $69,973	-5,281 Reduced 57.51%	3,902 $25,000
Q3 2021 Nov 15, 2021	SELL	$7.29 - $11.0 $55,710 - $84,062	-7,642 Reduced 45.42%	9,183 $83,000
Q2 2021 Aug 12, 2021	BUY	$9.87 - $13.32 $166,062 - $224,109	16,825 New	16,825 $196,000

8.41M

50K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $158M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.